Bonmax PTH 750mcg Injection
| Brand Name | Bonmax PTH |
| Generic Name | Teriparatide |
| Dosage Strength | 750mcg |
| Form | Injection |
| Route of Administration | Subcutaneous |
| Indication | Severe Osteoporosis, Bone Loss |
| Packaging | Prefilled Pen/Cartridge |
| Storage Condition | Store in refrigerator (2–8°C) |
| Prescription Status | Prescription Only |
Bonmax PTH 750mcg Injection
Bonmax PTH 750mcg Injection contains teriparatide, a medicine used to treat severe osteoporosis in men and postmenopausal women who are at high risk of fractures. It works by stimulating new bone formation, increasing bone density, and strengthening bones to lower the risk of fractures.
Bonmax PTH Injection is recommended when other osteoporosis treatments are not suitable or effective. With regular use under medical supervision, it helps improve bone strength and supports faster bone healing. This therapy is especially useful for patients with fragile bones or a previous fracture history.
Bonmax PTH 750 mcg Injection is a trusted product in the pharmaceutical industry for osteoporosis management. Developed under strict quality standards, this product delivers reliable therapeutic results and supports patient safety. Doctors recommend this pharmaceutical solution for comprehensive bone health care.
Product Features
- Effective treatment for severe osteoporosis
- Contains Teriparatide 750 mcg
- Stimulates natural bone formation
- Helps reduce fracture risk
- Clinically trusted pharmaceutical product
- Recommended for high-risk patients
- Supports long-term bone strength
How It Helps
- Increases bone density
- Promotes new bone growth
- Reduces fracture risk
- Improves overall bone strength

Reviews
There are no reviews yet.